FFPRHC Guidance (July 2004): Contraceptive choices for breastfeeding women

Journal of Family Planning and Reproductive Health Care

Volumn 30, Issue 3, 2004, Pages 181-189

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL; PROGESTERONE; SPERMICIDAL AGENT;

BREAKTHROUGH BLEEDING; BREAST FEEDING; CHILD GROWTH; CONTRACEPTION; FEMALE; FEMALE STERILIZATION; HORMONAL CONTRACEPTION; HUMAN; IMPLANT; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUAL CYCLE; MENSTRUATION; OVULATION; PATIENT COUNSELING; PATIENT INFORMATION; PRACTICE GUIDELINE; PUERPERIUM; REVIEW; RISK BENEFIT ANALYSIS; SEXUAL BEHAVIOR; SOCIAL ASPECT;

BREAST FEEDING; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE DEVICES; FEMALE; HUMANS; OVULATION; PATIENT EDUCATION; POSTPARTUM PERIOD; REPRODUCTIVE HEALTH SERVICES; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION;

EID: 3042818026     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/1471189041261429     Document Type: Review

References (77)

1. Hamlyn B, Brooker S, Oleinikova K, et al. Infant Feeding 2000. Norwich, UK: The Stationary Office, 2002.
2. World Health Organization (WHO). The Optimal Duration of Exclusive Breastfeeding. Report of an Expert Consultation, Geneva, Switzerland, 28-30 March 2001. Geneva, Switzerland: WHO, 2002.
3. World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use. Geneva, Switzerland: WHO, 2000.
4. World Health Organization (WHO). Selected Practice Recommendations for Contraceptive Use. Geneva, Switzerland: WHO, 2002.
5. Faculty of Family Planning and Reproductive Health Care (FFPRHC). UK Selected Practice Recommendations for Contraceptive Use. London, UK: FFPRHC, 2002.
6. Glasier A, Brechin S, Raine R, et al. A consensus process to adapt the World Health Organization Selected Practice Recommendations for UK use. Contraception 2003; 68: 327-333.
7. McNeilly AS. Neuroendocrine changes and fertility in breast-feeding women. Prog Brain Res 2001; 133: 207-214.
8. Glasier A, McNeilly AS, Howie PW. Hormonal background of lactational infertility. Int J Fertil 1988; 33: 32-34.
9. Glasier A, McNeilly AS. Physiology of lactation. Baillieres Clin Endocrinol Metab 1990; 4: 379-395.
10. Vlahos N, Zacur HH. Breastfeeding, prolactin, and ovulation during the puerperium. The Endocrinologist 1999; 9: 451-456.
11. Glasier A, McNeilly AS, Howie PW. Fertility after childbirth: changes in serum gonadotrophin levels in bottle and breast feeding women. Clin Endocrinol 1983; 19: 493-501.
12. Tay CCK, Glasier AF, McNeilly AS. The 24h pattern of pulsatile luteinizing hormone, follicle stimulating hormone and prolactin release during the first 8 weeks of lactational amenorrhoea in breastfeeding women. Hum Reprod 1992; 7: 951-958.
13. Glasier A, McNeilly AS, Howie PW. The prolactin response to suckling. Clin Endocrinol 1984; 21: 109-116.
14. McNeilly AS, Glasier AF, Howie PW, et al. Fertility after childbirth: pregnancy associated with breast feeding. Clin Endocrinol 1983; 18: 167-173.
15. McNeilly AS, Howie PW, Houston MJ, et al. Fertility after childbirth: adequacy of post-partum luteal phases. Clin Endocrinol 1982; 17: 609-615.
16. Faculty of Family Planning and Reproductive Health Care. Fertility awareness methods of family planning: the physiological background, methodology and effectiveness of fertility awareness methods. J Fam Plann Reprod Health Care 2001; 27: 103-110.
17. Knight J, Pyper C. Postnatal contraception: what are the choices? Nurs Pract 2002; May: 23-25.
18. Kennedy KI, Visness CM. Contraceptive efficacy of lactational amenorrhoea. Lancet 1992; 339: 227-230.
19. Van der Wijden C, Kleinen J. Lactational amenorrhea for family planning (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons.
20. World Health Organization Task Force on Methods for the Natural Regulation of Fertility. The WHO Multinational Study of Breastfeeding and Lactation Amenorrhoea. III. Pregnancy during breast-feeding. Fertil Steril 1999; 72: 431-440.
21. McGregor JA. Lactation and contraception. In: Neville MC, Neifert MR (eds), Lactation, Physiology, Nutrition and Breastfeeding. New York, NY: Plenum Press, 1983; 405-421.
22. Diaz S. Contraceptive implants and lactation. Contraception 2002; 65: 39-46.
23. Organon Laboratories Limited. Implanon. 1-13. 2004. http://www.emc. medicines.org.uk.
24. Heikkilä M, Haukkamaa M, Luukkainen T. Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD. Contraception 1982; 25: 41-49.
25. Nilsson S, Mellbin T, Hofvander Y, et al. Long-term follow-up of children breast-fed by mothers using oral contraceptives. Contraception 1986; 34: 443-457.
26. Jimenez J, Ochoa M, Soler MP, et al. Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate. Contraception 1984; 30: 523-533.
27. Pardthiasong T, Gray RH, McDaniel EB, et al. Steroid contraceptive use and pregnancy outcome. Teratology 1988; 38: 51-58.
28. Koetsawang S. The effects of contraceptive methods on the quality and quantity of breast milk. Int J Gynaecol Obstet 1987; 25: 115-127.
29. Lönnerdal B, Forsum E, Hambraeus L. Effect of oral contraceptives on composition and volume of breast milk. Am J Clin Nutr 1980; 33: 816-824.
30. Truitt ST, Fraser AB, Grimes DA, et al. Hormonal contraception during lactation: systematic review of randomized controlled trials. Contraception 2003; 68: 233-238.
31. Truitt ST, Fraser AB, Grimes DA, et al. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons.
32. Miller GH, Hughes LR. Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants. Obstet Gynecol 1970; 35: 44.
33. Semm K, Dittmar F. Postpartum ovulation: inhibition and milk yield. Curr Ther Res 1966; 8: 48.
34. Croxatto HB, Díaz S, Peralta O, et al. Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception 1983; 27: 13-25.
35. Gambrell RD. Immediate postpartum oral contraception. Obstet Gynecol 1970; 36: 101-106.
36. Tankeyoon M, Dusitain N, Chalapati S, et al. Effects of hormonal contraceptives on milk volume and infant growth: WHO special programme of research, development and research training in human reproduction. Contraception 1984; 30: 505-522.
37. Kaem T. Effects of an oral contraceptive immediately postpartum on initiation of lactation. BMJ 1967; 3: 644.
38. Garcia CR, Satterthwaite AP, Pinus G. Contraception using progestin-estrogen medication. Addendum to the Proceedings of the 7th Conference of the International Planned Parenthood Federation (IPPF), Singapore, 10-16 February 1963 (International Congress Series No. 72). Amsterdam, The Netherlands: Excerpta Medica, 1963.
39. Gomez-Rogers C, Ibarra Polo AA, Faudes A, et al. Effect of the IUD and other contraceptive methods on lactation. International Planned Parenthood Federation (IPPF) Proceedings of the 8th International Conference of the IPPF, Santiago, Chile, 9-15 April 1967. London, UK: IPPF, 1967; 328-334.
40. Koetsawang S, Bhiraleus P, Chiemprasert T. Effects of oral contraceptives on lactation. Fertil Steril 1972; 23: 24.
41. Guiloff E, Ibarra-Polo A, Zanartu J, et al. Effects of contraception on lactation. Am J Obstet Gynecol 1974; 118: 42.
42. Huber DH, Khan AR, Brown D, et al. Oral and injectable contraceptives: effects on breast milk and child growth in Bangladesh. In: Zatuchni GI, Labbok JJ, Sciarra JJ (eds). Research Frontiers in Fertility Regulation. Proceedings of an International Workshop on Research Frontiers in Fertility Regulation, Mexico City, Mexico, 11-14 February 1980. Hogerstown, MD: Harper and Row, 1980.
43. Kora SJ. Effect of oral contraceptives on lactation. Fertil Steril 1969; 20: 419.
44. Ibrahim A, El-Tawil NZ. The effect of new low-dosage contraceptive pill on lactation. Int Surg 1968; 49: 561.
45. Kamal I, Hefnawi F, Ghoneim M, et al. Clinical biomedical and experimental studies on lactation. 2. Clinical effects of gestagens on lactation. Am J Obstet Gynecol 1969; 105: 324.
46. Gupta AN, Mathur VS, Garg SK. Effect of oral contraceptives on quantity and quality of milk secretion in human beings. Indian J Med Res 1974; 62: 964-970.
47. Campodonico I, Gurrero B, Landa L. Effect of a low-dose oral contraceptive (150 mcg levonorgestrel and 30 mcg ethinyl estradiol) on lactation. Clin Ther 1978; 1: 454.
48. Salomon JBR. Hormonal contraception and maternal/infant nutrition. Fertil Steril 1977; 28: 382.
49. Karim K, Ammar R, Mahgoub E, et al. Injected progestogen and lactation. BMJ 1971; 1: 200-203.
50. Velazquez JG, Gallegos VC, Lopez AS, et al. Effects of the daily administration of 0.350 mg of norethindrone on breastfeeding and milk composition. Ginecol Obstet Mex 1976; 40: 31-39.
51. Bjarnadottir RI, Gottfredsdottir H, Sigurdardottir K. Desogestrel-only pill and breastfeeding. Br J Obstet Gynaecol 2001; 108: 1174-1180.
52. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon) on parameters of breastfeeding compared to those of an intrauterine device. Contraception 2000; 62: 239-246.
53. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health. J Fam Plann Reprod Health Care 2004; 30(2): 99-109.
54. Diaz S, Zepeda A, Maturana X, et al. Fertility regulation in nursing women IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implant, and copper T 380-A intrauterine devices. Contraception 1997; 56: 223-232.
55. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception. J Fam Plann Reprod Health Care 2004; 30(1): 29-42.
56. Aref I, Badraoui MHH, Hefnawi F. Contraception during lactation. Contracept Deliv Syst 1982; 3: 47-51.
57. Xu JX, Rivera R, Dunson TR, et al. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China. Contraception 1996; 54: 33-38.
58. Sivin I, Diaz S, Croxatto HB, et al. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the Copper T-380A IUD. Contraception 1997; 55: 225-232.
59. World Health Organization (WHO). WHO/CONRAD Technical Consultation on Nonoxynol-9, 9-10 October 2001. http://www.who.n-9meetingOct01.finalreport.doc.
60. NHS practitioners with specialist training in LAM and fertility awareness methods. 2004. http://www.fertilityuk.org.
61. Royal College of Obstetricians and Gynaecologists (RCOG). Male and Female Sterilisation. Guideline Summary (Evidence-based Clinical Guideline No. 4, January 2004). London, UK: RCOG Press, 2004; 1-18.
62. Butler SA, Khanlian SA, Cole LA. Detection of early pregnancy forms of human chorionic gonadotrophin by home pregnancy test devices. Clin Chem 2001; 47: 2131-2136.
63. Wilcox AJ, Day BD, Dunson D, et al. Natural limits of pregnancy testing in relation to the expected menstrual period. JAMA 2001; 286: 1759-1762.
64. Cole LA, Khanlian SA, Sutton JM, et al. Accuracy of home pregnancy tests at the time of missed menses. Am J Obstet Gynecol 2004; 190: 100-105.
65. Janssen-Cilag International NV. Evra Transdermal Patch. 1-16. 2002. http://www.emc.medicines.org.uk.
66. Wyeth Pharmaceuticals. Microval. 2003. http://www.emc.medicines.org.uk.
67. Pharmacia Limited. Femulen Tablets. 2002. http://www.emc.medicines.org. uk.
68. Janssen-Cilag Ltd. Micronor Oral Contraceptive Tablets. 2001. http://www.emc.medicines.org.uk.
69. Organon Laboratories Limited. Summary of Product Characteristics for Desogestrel-only Pill (Cerazette). 1-6. 2004. http://www.emc. medicines.org.uk.
70. Pharmacia Limited. Depo-Provera 150 mg/ml Injection. 1-6. 2002. http://www.emc.medicines.org.uk.
71. World Health Organization Special Programme. Effects of hormonal contraceptives on milk volume and infant growth. Contraception 1984; 30: 505-521.
72. Ratchanon S, Taneepanichskul S. Depot medroxyprogesterone acetate and basal serum prolacfin levels in lactating women. Obstet Gynecol 2000; 96: 926-928.
73. Hurley R, Asscher AW, Kennedy I, et al. Report of the panel of persons appointed by the licensing authority to hear the application by UpJohn Ltd for a product licence to market the drug Depo-Provera as a long-term contraceptive. London, UK: Department of Health and Social Security, 1984.
74. Mishell DRJ, Roy S. Copper intrauterine contraceptive device event rates following insertion 4, to 8 weeks post partum. Am J Obstet Gynecol 1982; 143: 29-35.
75. Schering Health Care Ltd. New dose instructions for Levonelle-2. http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?docu mentid=4231. 2003.
76. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (April 2003). Emergency contraception. J Fam Plann Reprod Health Care 2003; 29(2): 9-16.
77. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (October 2003). First prescription of combined oral contraception. J Fam Plann Reprod Health Care 2003; 29(4): 209-223.